Who Gets the HAART? Policy Implications for a Limited Resource
|
Posted 12.01.2011
|
World
Shouldn't we immediately ramp up access to HAART for everyone in the world who needs it? Of course we should. However, that's easier said than done. Providing universal ARV therapy globally will be expensive.
